LHC Group (LHCG)
(Delayed Data from NSDQ)
$114.82 USD
+2.44 (2.17%)
Updated May 3, 2019 04:00 PM ET
After-Market: $114.82 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$114.82 USD
+2.44 (2.17%)
Updated May 3, 2019 04:00 PM ET
After-Market: $114.82 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
LHC Group (LHCG) Q3 Earnings Match Estimates
by Zacks Equity Research
LHC (LHCG) delivered earnings and revenue surprises of 0.00% and 0.03%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate LHC Group (LHCG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LHC (LHCG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LHC Group (LHCG) Reports Impressive Preliminary Q3 Revenues
by Zacks Equity Research
Growth in LHC Group's (LHCG) revenues in the third quarter is likely to have been boosted by continued strength in its home health and hospice services.
LHC Group (LHCG) Finalizes Home Health & Hospice Buyout Deals
by Zacks Equity Research
LHC Group (LHCG) to expand in Virginia Beach with the completion of the previously announced acquisition agreements with two providers, one in home health and the other in hospice.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Hold on to LHC Group (LHCG) Stock Now
by Zacks Equity Research
LHC Group (LHCG) continues to benefit from strategic deals and broad array of services.
LHC Group (LHCG) to Boost Nationwide Presence With New Buyout
by Zacks Equity Research
LHC Group's (LHCG) deal win enables the company to acquire home health, hospice and therapy assets in 22 states.
LHC Group (LHCG) Closes Heart of Hospice Buyout, Expands Presence
by Zacks Equity Research
LHC Group (LHCG) expands its hospice presence in five states with the completion of Heart of Hospice buyout.
Why Is LHC (LHCG) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
LHC (LHCG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health's (EHC) Growth View Makes It a Good Buy
by Sapna Bagaria
Ageing population, building of hospitals and other operational efforts poise Encompass Health (EHC) well for long-term growth, thus making it a good investment option.
Here's Why You Should Hold on to LHC Group (LHCG) Stock Now
by Zacks Equity Research
LHC Group (LHCG) continues to benefit from strategic deals and broad array of services.
LHC Group (LHCG) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
LHC Group (LHCG) has been struggling lately, but the selling pressure may be coming to an end soon.
LHC Group (LHCG) Stock Loses 11.9% Despite Q2 Earnings Beat
by Zacks Equity Research
LHC Group's (LHCG) second-quarter results benefit from organic growth in both home health and hospice admissions.
LHC Group (LHCG) Q2 Earnings Top Estimates
by Zacks Equity Research
LHC (LHCG) delivered earnings and revenue surprises of 4.52% and -1.01%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
LHC Group (LHCG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
LHC (LHCG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons to Add LHC Group (LHCG) Stock to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about LHC Group (LHCG) owing to its slew of deals and a broad array of services.
LHC Group (LHCG) & SCP Health to Offer Home Health Services
by Zacks Equity Research
LHC Group (LHCG) collaborates with SCP Health to provide innovative and advanced in-home healthcare services.
LHC Group (LHCG) Boosts Home Health, Hospice Arms With Buyouts
by Zacks Equity Research
LHC Group's (LHCG) three new buyouts and completion of previous acquisitions will enable the company to bolster its home health and hospice presence throughout seven states.
Encompass Health (EHC) to Expand Inpatient Rehabilitation Unit
by Zacks Equity Research
Encompass Health (EHC) to construct an inpatient rehabilitation hospital to capture a market with great prospects.
5 Reasons That Make Encompass Health (EHC) an Attractive Bet
by Zacks Equity Research
Encompass Health's (EHC) optimistic business prospects make it a lucrative stock to own for strong gains.
Encompass Health (EHC) Expands Inpatient Rehab Business
by Zacks Equity Research
Encompass Health (EHC) continues to strengthen its inpatient rehabilitation business by opening a hospital.
Here's Why You Should Retain LHC Group (LHCG) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about LHC Group (LHCG) owing to its slew of buyouts and a broad array of services.
LHC (LHCG) Down 3.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
LHC (LHCG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LHC Group (LHCG) Expands Hospice Presence with New Buyout
by Zacks Equity Research
LHC Group (LHCG) agrees to purchase Heart of Hospice to extend its hospice footprint in five states.
Veeva Systems (VEEV) Q1 Earnings Beat Estimates, '22 View Up
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performance by both its segments.